IGM ANTI-FC-GAMMA-R AUTOANTIBODIES TRIGGER NEUTROPHIL DEGRANULATION

Anti-Fc-gamma-R IgM monoclonal antibodies (mAbs) isolated from lipopolysaccharide-stimulated spleen cells from tightskin (TSK) mice were found to be polyspecific, reacting with a wide variety of molecules, including doulbe-stranded DNA, topoisomerase, RNA polymerase, and different collagen types. Approximately 60% of the polyspecific IgM mAbs have anti-Fc-gamma-R specificity. These anti-Fc-gamma-R mAbs induce the release of hydrolases from both azurophil and specific granules of human neutrophils. 25-45% of the total cellular content (determined in Nonidet P-40 lysates) of neutrophil elastase, 10-25% of beta-glucuronidase, and 30-50% of alkaline phosphatase was released after incubation with the mAbs. The degranulation process was accompanied by dramatic morphological changes shown by scanning and transmission electron microscopy. The release of hydrolytic enzymes stimulated by the IgM anti-Fc-gamma-R mAbs was inhibited by preincubation of neutrophils with Fab fragments of either anti-human Fc-gamma-RII (IV.3) or anti-human Fc-gamma-RIII (3G8) mAbs. The binding of the anti-Fc-gamma-R TSK mAbs to human neutrophils was inhibited by Fab fragments of mAb 3G8. However, we found that the TSK anti-Fc-gamma-R mAbs do not bind to human Fc-gamma-RII expressed in either CHO cells or the P388D1 mouse macrophage cell line. Since the enzyme release could be inhibited by Fab fragments of mAb IV.3, we suggest that the signal transduction may require Fc-gamma-RII activation subsequent to crosslinking of the glycan phosphatidyl inositol-anchored Fc-gamma-RIII-1. These data demonstrate for the first time that polyspecific autoantibodies with Fc-gamma-R specificity can trigger neutrophil enzyme release via human Fc-gamma-RIII-1 in vitro and indicate a possible role for such autoantibodies in autoimmune inflammatory processes.